4.3 Article

Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition

Journal

VIRCHOWS ARCHIV
Volume 477, Issue 2, Pages 241-248

Publisher

SPRINGER
DOI: 10.1007/s00428-020-02748-1

Keywords

Tumor budding; Epithelial-mesenchymal transition (EMT); Sinonasal cavities; Intestinal-type adenocarcinoma

Categories

Ask authors/readers for more resources

Intestinal-type adenocarcinoma (ITAC) of sinonasal tract is a rare malignant tumor with strong morphological, immunophenotypical, and molecular similarities to colorectal adenocarcinoma (CRC). Tumor budding (TB) is a well-established adverse prognostic marker in CRC and some head and neck tumors, with features of epithelial-mesenchymal transition (EMT). The aim of this study was to assess TB in ITAC and to evaluate its possible association with EMT markers in this setting. We selected 32 surgically resected specimens of non-mucinous/non-signet ring ITAC and evaluated them for TB according to the international recommendations developed for CRC. The expression of the EMT markers E-cadherin, ZEB1, ZEB2, SLUG, and SNAIL was evaluated by immunohistochemistry (IHC). Results were stratified using clinical and follow-up data (2/32 patients had metastatic disease and 4/32 died of disease). We observed TB in 13/32 (40.6%) ITAC cases including the 7 patients with relapse (p = 0.0005) and the 4 patients dead of disease (p = 0.02). Lymphovascular invasion was associated with TB (p = 0.008). Absence of TB was associated with low ZEB2 expression (p = 0.003). No other association with EMT markers emerged. Occupational exposure to wood and leather dust was not related to the presence of TB. TB interobserver concordance was substantial (proportion of agreement = 87%; Cohen's kappa = 0.73). This work suggests that TB is associated with a worse prognosis in ITAC, but our findings do not seem to support the involvement of EMT in this specific setting. Further larger studies are needed to address this point.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pathology

Epstein-Barr virus associated gastric dysplasia: a new rare entity?

Valentina Angerilli, Francesca Galuppini, Gianmaria Pennelli, Giuseppe Nicolo' Fanelli, Emanuele S. G. d'Amore, Mauro Michelotto, Pierluigi Pilati, Gaya Spolverato, Salvatore Pucciarelli, Marco Scarpa, Fabio Farinati, Edoardo Savarino, Stefano Realdon, Sara Lonardi, Francesca Bergamo, Fotios Loupakis, Angelo Paolo Dei Tos, Alessandro Vanoli, Matteo Fassan

Summary: The study presented an unusual case of EBV-associated gastric dysplasia, suggesting a possible early direct role of EBV in gastric carcinogenesis. It also indicated that non-conventional EBV-associated dysplasia may represent a novel histopathological entity in the context of gastric dysplasia.

VIRCHOWS ARCHIV (2022)

Article Pathology

Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series

Giovanni Zarrilli, Valentina Angerilli, Rocco Cappellesso, Francesca Galuppini, Gianmaria Pennelli, Fabio Farinati, Lorenzo Nicole, Edoardo Savarino, Stefano Realdon, Gaia Griguolo, Michele Bottosso, Maria Vittoria Dieci, Valentina Guarneri, Angelo Paolo Dei Tos, Marcello Lo Mele, Matteo Fassan

Summary: The metastatic spread of breast carcinoma to the stomach is rare and often poses a diagnostic challenge. This study retrospectively identified 23 cases of gastric metastases from breast cancer and analyzed their histotype, localization, appearance, and architecture. The findings suggest that immunohistochemistry, specifically a panel of cytokeratins 7 and 20, Estrogen and Progesteron Receptors, can significantly improve diagnostic accuracy.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Article Endocrinology & Metabolism

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling

Francesca Galuppini, Simona Censi, Isabella Merante Boschin, Matteo Fassan, Marta Sbaraglia, Nicola Valeri, Jens Claus Hahne, Loris Bertazza, Giada Munari, Marco Galasso, Luciano Cascione, Susi Barollo, Massimo Rugge, Federica Vianello, Angelo Paolo Dei Tos, Caterina Mian, Gianmaria Pennelli

Summary: This study analyzed the miRNA expression profiles of different histological variants and mutations in papillary thyroid carcinoma (PTC) samples and found that miRNA signatures were associated with specific histotypes and BRAF mutations.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Health Care Sciences & Services

Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, Alessandro Volpe, Luca Cima, Maria Rosaria Raspollini, Mattia Barbareschi, Alessandro Tafuri, Giulia Masi, Luisa Barzon, Serena Ammendola, Manuela Villanova, Maria Angela Cerruto, Michele Milella, Sebastiano Buti, Melissa Bersanelli, Giuseppe Fornarini, Sara Elena Rebuzzi, Valerio Gaetano Vellone, Gabriele Gaggero, Giuseppe Procopio, Elena Verzoni, Sergio Bracarda, Martina Fanelli, Roberto Sabbatini, Rodolfo Passalacqua, Bruno Perrucci, Maria Olga Giganti, Maddalena Donini, Stefano Panni, Marcello Tucci, Veronica Prati, Cinzia Ortega, Anna Calio, Albino Eccher, Filippo Alongi, Giovanni Pappagallo, Roberto Iacovelli, Alessandra Mosca, Paolo Umari, Ilaria Montagnani, Stefano Gobbo, Francesco Atzori, Enrico Munari, Marco Maruzzo, Umberto Basso, Francesco Pierconti, Carlo Patriarca, Piergiuseppe Colombo, Alberto Lapini, Giario Conti, Roberto Salvioni, Enrico Bollito, Andrea Cossarizza, Francesco Massari, Mimma Rizzo, Renato Franco, Federica Zito-Marino, Yoseba Aberasturi Plata, Francesca Galuppini, Marta Sbaraglia, Matteo Fassan, Angelo Paolo Dei Tos, Maurizio Colecchia, Holger Moch, Maurizio Scaltriti, Camillo Porta, Brett Delahunt, Gianluca Giannarini, Roberto Bortolus, Pasquale Rescigno, Giuseppe Luigi Banna, Alessio Signori, Miguel Angel Llaja Obispo, Roberto Perris, Alessandro Antonelli

Summary: This study aims to overcome intratumoral heterogeneity in clear cell renal cell carcinoma (clearRCC). By using a multisite 3D fusion sampling method, heterogeneity in angiogenic and immune markers was observed. Additionally, this method can uncover new morphological features and provide more accurate pathological assessment.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Gastroenterology & Hepatology

Histopathological Landscape of Precursor Lesions of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms

Rachele Biancotti, Carlo Alberto Dal Pozzo, Paola Parente, Gianluca Businello, Valentina Angerilli, Stefano Realdon, Edoardo Vincenzo Savarino, Fabio Farinati, Anna Caterina Milanetto, Claudio Pasquali, Roberto Vettor, Federica Grillo, Gianmaria Pennelli, Claudio Luchini, Luca Mastracci, Alessandro Vanoli, Massimo Milione, Francesca Galuppini, Matteo Fassan

Summary: This review focuses on the precursor lesions of neuroendocrine tumors in the gastro-entero-pancreatic tract. It distinguishes well-recognized pathophysiological and morphological entities with eventual molecular correlations from those in which the preneoplastic changes are still unclear. The aim of the paper is to provide a useful tool for future research in understanding the underlying biology and early development of gastro-entero-pancreatic neuroendocrine tumors.

DIGESTIVE DISEASES (2023)

Article Pathology

Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes

Valentina Angerilli, Gianmaria Pennelli, Francesca Galuppini, Stefano Realdon, Alberto Fantin, Edoardo Savarino, Fabio Farinati, Luca Mastracci, Claudio Luchini, Matteo Fassan

Summary: The study on gastroesophageal dysplastic lesions revealed heterogeneity in TCGA/ACRG classes, with different distribution from cancers and positive associations found between different subtypes.

VIRCHOWS ARCHIV (2022)

Article Oncology

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation

Irene Tizianel, Mario Caccese, Francesca Torresan, Giuseppe Lombardi, Laura Evangelista, Filippo Crimi, Matteo Sepulcri, Maurizio Iacobone, Marta Padovan, Francesca Galuppini, Vittorina Zagonel, Carla Scaroni, Filippo Ceccato

Summary: The study found a significant improvement in survival rates for ACC patients after multidisciplinary team evaluation in 2013. Therefore, it is suggested that ACC patients should be referred to a tertiary center from the time of diagnosis in order to promptly apply all available treatments.

CANCERS (2022)

Meeting Abstract Oncology

Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study

S. E. Rebuzzi, P. Rescigno, A. Signori, M. Brunelli, F. Galuppini, V. G. Vellone, G. Gaggero, M. Maruzzo, M. Milella, F. Vignani, A. Cavo, U. Basso, F. Catalano, V. Murianni, M. Cremante, A. Damassi, M. A. Llaja Obispo, G. L. Banna, S. Buti, G. Fornarini

ANNALS OF ONCOLOGY (2022)

Review Oncology

The evolving landscape of anatomic pathology

Pasquale Pisapia, Vincenzo L'Imperio, Francesca Galuppini, Elham Sajjadi, Alessandro Russo, Bruna Cerbelli, Filippo Fraggetta, Giulia D'Amati, Giancarlo Troncone, Matteo Fassan, Nicola Fusco, Fabio Pagni, Umberto Malapelle

Summary: Anatomic pathology has undergone significant changes in recent years, with molecular profiling becoming equally important in cancer diagnosis. Modern pathologists must acquire additional knowledge in predictive molecular pathology to bridge the gap between clinicians and molecular biologists, and they play a growing role in the management of cancer patients.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Article Oncology

Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients

Francesca Torresan, Simona Censi, Gianmaria Pennelli, Francesca Galuppini, Caterina Mian, Maurizio Iacobone

Summary: The study demonstrates that prophylactic and early thyroidectomy are safe and effective procedures for RET mutation carriers, achieving definitive cure in most cases. However, there is a risk of long-term recurrence, even in cases with small and localized MTC, emphasizing the importance of early prophylactic surgery to prevent microMTC development.

CANCERS (2022)

Review Oncology

Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review

Davide Bimbatti, Nicolo Cavasin, Francesca Galuppini, Alessandro Rago, Gaetano Ramondo, Eleonora Lai, Michele Dionese, Elisa Erbetta, Umberto Basso, Marco Maruzzo

Summary: This article presents a rare case of renal cell carcinoma (RCC) that initially presented with multiple liver and lymph node metastases but no primary renal lesion. The patient achieved an impressive response to treatment with a combination of immune checkpoint inhibitors and tyrosine kinase inhibitors. A multidisciplinary approach and diagnostic strategy are crucial for reaching a definitive diagnosis and selecting the appropriate treatment for mRCC without a primary tumor.

ANTICANCER RESEARCH (2023)

Article Oncology

Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study

Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, Valerio Gaetano Vellone, Alessio Signori, Fabio Catalano, Alessandra Damassi, Gabriele Gaggero, Pasquale Rescigno, Marco Maruzzo, Sara Merler, Francesca Vignani, Alessia Cavo, Umberto Basso, Michele Milella, Olimpia Panepinto, Manlio Mencoboni, Marta Sbaraglia, Angelo Paolo Dei Tos, Veronica Murianni, Malvina Cremante, Miguel Angel Llaja Obispo, Michele Maffezzoli, Giuseppe Luigi Banna, Sebastiano Buti, Giuseppe Fornarini

Summary: This study identified differential immunohistochemical patterns in the tumors of patients who responded and did not respond to nivolumab, an immunotherapy. Tumors in responders showed poor presence of CD4+ immune cells, high expression of CD56 on tumor cells, and high expression of phosphorylated mTOR protein. Further investigation with genomic analysis is planned to examine the prognostic role of the tumor microenvironment.

CANCERS (2023)

Article Oncology

Long-Term Outcomes after Surgery for Pheochromocytoma and Sympathetic Paraganglioma

Francesca Torresan, Arianna Beber, Donatella Schiavone, Stefania Zovato, Francesca Galuppini, Filippo Crimi, Filippo Ceccato, Maurizio Iacobone

Summary: The study analyzed the long-term outcomes in 170 patients who underwent surgery for pheochromocytoma and sympathetic paraganglioma (PHEO/sPGL). It was found that even apparently benign and sporadic variants had a risk of long-term recurrence, highlighting the importance of lifelong follow-up.

CANCERS (2023)

Meeting Abstract Orthopedics

EFFICACY EVALUATION OF INTRA-ARTICULAR INJECTION OF AN ALENDRONATE-HYALURONIC ACID CONJUGATE IN AN IN VIVO MODEL OF OSTEOARTHRITIS

A. Scanu, R. Luisetto, M. Pavan, C. Guarise, R. Beninatto, C. Giraudo, F. Galuppini, V. Lazzarin, V. Guzzardo, G. Pennelli, D. Galesso, S. Masiero

OSTEOARTHRITIS AND CARTILAGE (2022)

Article Endocrinology & Metabolism

Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up?

Simona Censi, Antonio De Rosa, Francesca Galuppini, Jacopo Manso, Loris Bertazza, Isabella Merante-Boschin, Mario Plebani, Diego Faggian, Gianmaria Pennelli, Susi Barollo, Federica Vianello, Maurizio Iacobone, Caterina Mian

Summary: The study found that in some patients with persistent or recurrent DTC, serum Tg levels were undetectable, and the reasons for this phenomenon remain unknown. However, for low/intermediate-risk patients cured at one-year follow-up, using highly sensitive Tg without neck ultrasounds seems to be an appropriate management strategy.

ENDOCRINE (2022)

No Data Available